Tsai Chen Lung 4/A

What Happened Tsai Chen Lung, a director of CapsoVision, acquired 20 shares on July 3, 2025, in an open-market purchase at $4.17 per share, for a total transaction value of $83. This filing is an amendment to the original Form 4 and corrects an inadvertent omission of the trade. A small purchase like this is generally routine and does not on its own indicate a material change in insider sentiment.

Key Details

• Transaction date and price: 2025-07-03, 20 shares at $4.17 each (total $83).
• Transaction type: Purchase (code P) — open market/private purchase.
• Shares owned after transaction: Not provided in the details supplied.
• Footnote: F1 — Shares are held by the reporting person and his wife in a joint brokerage account.
• Timeliness: This is an AMENDED Form 4. The transaction was inadvertently omitted from the original Form 4 filed July 7, 2025, so the filing is corrective/late.

Context Purchases by insiders can be interpreted as a mild bullish signal, but the very small size of this trade ($83) suggests a routine personal transaction rather than a material investment decision. The amendment improves transparency by reporting the previously omitted trade; late or corrected filings reduce reporting timeliness but are commonly remedied via amendments.